According to Foreign Ministry Sources, the Central Government has reportedly put on temporary hold all major exports of Oxford-AstraZeneca’s Covishield vaccine.
On Friday 1st January, an expert panel on Covid-19 of the CDSCO recommended that permission should be granted for restricted emergency use of Oxford COVID-19 vaccine Covishield in India.
A top official at the Serum Institute of India said India will get its first coronavirus vaccine named Covishield in 73 days.
The COVID-19 vaccine developed by researchers at Oxford University in the United Kingdom, has been confirmed to be safe and effective.